跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75 mg tablet blister pack
Approved
STANDARD
RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75 mg tablet blister pack
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
2a56fba8a7059f8c
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
2a56fba8a7059f8c
Product Name
RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75 mg tablet blister pack
Artg Id
181976
Artg Name
RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75 mg tablet blister pack
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2012-03-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/d522bad9187991f6b7b54b75f917fc38.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
2a56fba8a7059f8c
Type
Standard
Back to TGA Approvals